A Descriptive Study of Morphoea with Clinico-Pathological Correlation
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Dermoscopy of Inflammatory Dermatoses (Inflammoscopy): an Up-To-Date Overview
Dermatology Practical & Conceptual Dermoscopy of Inflammatory Dermatoses (Inflammoscopy): An Up-to-Date Overview Enzo Errichetti1 1 Institute of Dermatology, Santa Maria della Misericordia University Hospital, Udine, Italy Key words: dermoscopy, differential diagnosis, general dermatology, inflammoscopy Citation: Errichetti E. Dermoscopy of inflammatory dermatoses (inflammoscopy): an up-to-date overview. Dermatol Pract Concept. 2019;9(3):169-180. DOI: https://doi.org/10.5826/dpc.0903a01 Accepted: June 2, 2019; Published: July 31, 2019 Copyright: ©2019 Errichetti. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Funding: None. Competing interests: The author has no conflicts of interest to disclose. Authorship: The author takes responsibility for this publication. Corresponding author: Enzo Errichetti, MD, MSc, Institute of Dermatology, Santa Maria della Misericordia University Hospital, Piazzale Santa Maria della Misericordia, 15, 33100 Udine, Italy. Email: [email protected] ABSTRACT In addition to its use in pigmented and nonpigmented skin tumors, dermoscopy is gaining apprecia- tion in assisting the diagnosis of nonneoplastic diseases, especially inflammatory dermatoses (inflam- moscopy). In this field, dermoscopic examination should be considered as the second step of a “2-step procedure,” always preceded by the establishment of a differential diagnosis on the basis of clinical examination. In this paper, we sought to provide an up-to-date overview on the use of dermoscopy in common inflammatory dermatoses based on the available literature data. For practical purposes, the analyzed dermatoses are grouped according to the clinical presentation pattern, in line with the 2-step procedure principle: erythematous-desquamative and papulosquamous dermatoses, papulokeratotic dermatoses, erythematous facial dermatoses, sclero-atrophic dermatoses, and miscellaneous. -
(12) United States Patent (10) Patent No.: US 7,359,748 B1 Drugge (45) Date of Patent: Apr
USOO7359748B1 (12) United States Patent (10) Patent No.: US 7,359,748 B1 Drugge (45) Date of Patent: Apr. 15, 2008 (54) APPARATUS FOR TOTAL IMMERSION 6,339,216 B1* 1/2002 Wake ..................... 250,214. A PHOTOGRAPHY 6,397,091 B2 * 5/2002 Diab et al. .................. 600,323 6,556,858 B1 * 4/2003 Zeman ............. ... 600,473 (76) Inventor: Rhett Drugge, 50 Glenbrook Rd., Suite 6,597,941 B2. T/2003 Fontenot et al. ............ 600/473 1C, Stamford, NH (US) 06902-2914 7,092,014 B1 8/2006 Li et al. .................. 348.218.1 (*) Notice: Subject to any disclaimer, the term of this k cited. by examiner patent is extended or adjusted under 35 Primary Examiner Daniel Robinson U.S.C. 154(b) by 802 days. (74) Attorney, Agent, or Firm—McCarter & English, LLP (21) Appl. No.: 09/625,712 (57) ABSTRACT (22) Filed: Jul. 26, 2000 Total Immersion Photography (TIP) is disclosed, preferably for the use of screening for various medical and cosmetic (51) Int. Cl. conditions. TIP, in a preferred embodiment, comprises an A6 IB 6/00 (2006.01) enclosed structure that may be sized in accordance with an (52) U.S. Cl. ....................................... 600/476; 600/477 entire person, or individual body parts. Disposed therein are (58) Field of Classification Search ................ 600/476, a plurality of imaging means which may gather a variety of 600/162,407, 477, 478,479, 480; A61 B 6/00 information, e.g., chemical, light, temperature, etc. In a See application file for complete search history. preferred embodiment, a computer and plurality of USB (56) References Cited hubs are used to remotely operate and control digital cam eras. -
Dermatoscopic Findings of Pigmented Purpuric Dermatosis*
584 INVESTIGATION s Dermatoscopic findings of pigmented purpuric dermatosis* Dilek Biyik Ozkaya1 Nazan Emiroglu1 Ozlem Su1 Fatma Pelin Cengiz1 Anil Gulsel Bahali1 Pelin Yildiz1 Cuyan Demirkesen2 Nahide Onsun1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20165124 Abstract: BACKGROUND: Pigmented purpuric dermatosis is a chronic skin disorder of unknown aetiology characterised by sym- metrical petechial and pigmented macules, often confined to the lower limbs. The aetiology of pigmented purpuric dermatosis is unknown. Dermatoscopy is a non-invasive diagnostic technique that allows the visualisation of morphological features invisible to the naked eye; it combines a method that renders the corneal layer of the skin translucent with an optical system that magnifies the image projected onto the retina. OBJECTIVES: The aim of this study is to investigate the dermatoscopic findings of pigmented purpuric dermatosis. METHODS: This study enrolled patients diagnosed histopathologically with pigmented purpuric dermatosis who had derma- toscopic records. We reviewed the dermatoscopic images of PPD patients who attended the outpatient clinic in the Istanbul Dermatovenereology Department at the Bezmialem Vakıf University Medical Faculty. RESULTS: Dermatoscopy showed: coppery-red pigmentation (97%, n = 31) in the background, a brown network (34%, n = 11), linear vessels (22%, n = 7), round to oval red dots, globules, and patches (69%, n = 22; 75%, n = 24; 34%, n = 11; respectively), brown globules (26%, n = 8) and dots (53%, n = 17), linear brown lines (22%, n = 7), and follicular openings (13%, n = 4). CONCLUSION: To our knowledge, this is the first study to report the dermatoscopy of pigmented purpuric dermatosis. In our opinion, dermatoscopy can be useful in the diagnosis of pigmented purpuric dermatosis. -
Mallory Prelims 27/1/05 1:16 Pm Page I
Mallory Prelims 27/1/05 1:16 pm Page i Illustrated Manual of Pediatric Dermatology Mallory Prelims 27/1/05 1:16 pm Page ii Mallory Prelims 27/1/05 1:16 pm Page iii Illustrated Manual of Pediatric Dermatology Diagnosis and Management Susan Bayliss Mallory MD Professor of Internal Medicine/Division of Dermatology and Department of Pediatrics Washington University School of Medicine Director, Pediatric Dermatology St. Louis Children’s Hospital St. Louis, Missouri, USA Alanna Bree MD St. Louis University Director, Pediatric Dermatology Cardinal Glennon Children’s Hospital St. Louis, Missouri, USA Peggy Chern MD Department of Internal Medicine/Division of Dermatology and Department of Pediatrics Washington University School of Medicine St. Louis, Missouri, USA Mallory Prelims 27/1/05 1:16 pm Page iv © 2005 Taylor & Francis, an imprint of the Taylor & Francis Group First published in the United Kingdom in 2005 by Taylor & Francis, an imprint of the Taylor & Francis Group, 2 Park Square, Milton Park Abingdon, Oxon OX14 4RN, UK Tel: +44 (0) 20 7017 6000 Fax: +44 (0) 20 7017 6699 Website: www.tandf.co.uk All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior permission of the publisher or in accordance with the provisions of the Copyright, Designs and Patents Act 1988 or under the terms of any licence permitting limited copying issued by the Copyright Licensing Agency, 90 Tottenham Court Road, London W1P 0LP. Although every effort has been made to ensure that all owners of copyright material have been acknowledged in this publication, we would be glad to acknowledge in subsequent reprints or editions any omissions brought to our attention. -
Key Words, General Index
Key words, general index (1/1991-4/2018) The number on the left indicates the initial page of the original article, whereas the number on the right of the bar-line indicates the year of publication of European Journal of Pediatric Dermatology. The numbers followed by “t” refer to the page of the Practical Pediatric Dermatology; the numbers followed by “d” refer to the page of the Pediatric Dermoscopy Book. They are followed, after the bar-line, by the year of publication. Absorption, percutaneous ALDY 182/16 tongue 233/05 newborn 157/91 (vs) superficial morphea 132/16 Angioma, eruptive Acanthosis nigricans 85/03 Allergic contact dermatitis satellitosis 207/10 Crouzon, syndrome 209/96 airborne 29/18 topical timolol 213/16 Acetominophen minoxidil 122/17 Angioma, flat, midline 81/03 fixed drug eruption 123/17 henné 93/03, 55/11 and lateral 149/99 Acitretin 151/09 propranolol 122/14 Angioma, lobular, pruritus 63/18 (and) psoriasis 120/09 eruptive 481t/00 Acne 337t/98 topical corticosteroids 29/01 palmar 91/06 (vs) angiofibromas 135/99 Allergy, rubber 215/01 Angioma, microvenular 33/97 port-wine 256/11 Allergy, food Angioma, port-wine 156/10 questionnaire 32/18 alternative medicine 165/03 Angioma, tufted 210/03, violinist 120/11 Alopecia, androgenetic 56/16 154/09, 233/12 Acne Alopecia, break dance 92/06, 254/15 Anhidrosis cystic rosacea-like 7/13 Alopecia areata 63/09 peripheral neuropathy 237/12 (and) vascular lesions 186/18 dermoscopy 132/09, 133/09 Anisakis Acne, neonatal Down 7/14 atopic dermatitis 109/08 (vs) atopic dermatitis 10/92 incognita 187/14 Anitis, streptococcal 19/09 retinoids 81/98 neonatal 56/11, 252/14 Anonychia, congenital 253/08 Acne, steroid 282/12 tacrolimus 227/07 Anticonvulsant drugs Acne, vulgaris 185/10 Alopecia, androgenetic hyperpigmentation 64/18 Acremoniasis 71/11 tricho-rhino-phalangeal s. -
Pigmented Purpuric Dermatosis: a Review of the Literatureଝ
Actas Dermosifiliogr. 2020;111(3):196---204 REVIEW Pigmented Purpuric Dermatosis: A Review of the Literatureଝ ∗ I. Martínez Pallás, R. Conejero del Mazo, V. Lezcano Biosca Servicio de Dermatología y Venereología, Hospital Clínico Lozano Blesa, Zaragoza, Spain Received 21 October 2018; accepted 24 February 2019 Available online 20 March 2020 KEYWORDS Abstract The pigmented purpuric dermatoses (PPDs) are a group of benign, chronic diseases. The variants described to date represent different clinical presentations of the same entity, Purpuric pigmented dermatosis; all having similar histopathologic characteristics. We provide an overview of the most common Review; PPDs and describe their clinical, dermatopathologic, and epiluminescence features. PPDs are both rare and benign, and this, together with an as yet poor understanding of the pathogenic Clinical presentation; Treatment mechanisms involved, means that no standardized treatments exist. We review the treatments described to date. However, because most of the descriptions are based on isolated cases or small series, there is insufficient evidence to support the use of any of these treatments as first-line therapy. © 2019 AEDV. Published by Elsevier Espana,˜ S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). PALABRAS CLAVE Dermatosis purpúricas pigmentadas. Revisión de la literatura científica Dermatosis purpúrico pigmentadas; Resumen Las dermatosis purpúrico pigmentadas (DPP) son un grupo de enfermedades benig- Revisión; nas y de curso crónico. Las variantes descritas representan distintas formas clínicas de una misma entidad con unas características histopatológicas comunes para todas ellas. Exponemos Presentación clínica; Tratamiento a continuación un resumen de las variedades más frecuentes, sus características clínicas, der- matopatológicas y de epiluminiscencia. -
Review Skin Changes Are One of the Earliest Signs of Venous a R T I C L E Hypertension
p-p - ABSTRACT Review Skin changes are one of the earliest signs of venous A R T I C L E hypertension. Some of these changes such as venous eczema are common and easily identified whereas DERMATOLOGICAL other changes such as acroangiodrmatitis are less common and more difficult to diagnose. Other vein MANIFESTATIONS OF VENOUS related and vascular disorders can also present with specific skin signs. Correct identification of these DISEASE: PART I skin changes can aid in making the right diagnosis and an appropriate plan of management. Given KUROSH PARSI, the significant overlap between phlebology and Departments of Dermatology, St. Vincent’s Hospital and dermatology, it is essential for phlebologists to be Sydney Children’s Hospital familiar with skin manifestations of venous disease. Sydney Skin & Vein Clinic, This paper is the first installment in a series of 3 Bondi Junction, NSW, Australia and discusses the dermatological manifestations of venous insufficiency as well as other forms of vascular ectasias that may present in a similar Introduction fashion to venous incompetence. atients with venous disease often exhibit dermatological Pchanges. Sometimes these skin changes are the only clue to an appropriate list of differential diagnoses. Venous ulceration. Less common manifestations include pigmented insufficiency is the most common venous disease which purpuric dermatoses, and acroangiodermatitis. Superficial presents with a range of skin changes. Most people are thrombophlebitis (STP) can also occur in association with familiar with venous eczema, lipodermatosclerosis and venous incompetence but will be discussed in the second venous ulcers as manifestations of long-term venous instalment of this paper (Figure 2). -
Contact Dermatitis: a Great Imitator
CID-07389; No of Pages 17 Clinics in Dermatology (xxxx) xx,xxx Contact dermatitis: a great imitator Ömer Faruk Elmas,MDa,⁎, Necmettin Akdeniz,MDb, Mustafa Atasoy,MDc, Ayse Serap Karadag,MDb aDepartment of Dermatology, Faculty of Medicine, Ahi Evran University, Kırşehir, Turkey bDepartment of Dermatology, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey cDepartment of Dermatology, Kayseri City Hospital, Health Science University, Kayseri, Turkey Abstract Contact dermatitis (CD) refers to a group of cutaneous diseases caused by contact with allergens or irritants. It is characterized by different stages of an eczematous eruption and has the ability to mimic a wide variety of dermatologic conditions, including inflammatory dermatitis, infectious conditions, cutaneous lymphoma, drug eruptions, and nutritional deficiencies. Irritant CD and allergic CD are the two main presen- tations of the disease. The diagnosis is based on a detailed history, physical examination, and patch testing, if necessary. Knowing the conditions mimicked by CD should improve the accuracy of the diagnosis. Avoid- ing the causative substances and taking preventive measures are necessary for the treatment. © 2019 Elsevier Inc. All rights reserved. Introduction Epidemiology Contact dermatitis (CD) describes a group of skin diseases CD can be seen at any age, and its estimated prevalence caused by contact allergens or irritant substances. CD is ranges from 1.7% to 6.3% in various published studies.3 It is characterized by an eczematous eruption and can imitate many more common in urban areas, with the incidence being higher dermatologic conditions.1,2 Irritant contact dermatitis (ICD) in women and the elderly.3 Many studies, however, suggest and allergic contact dermatitis (ACD) are considered as the that sex and age cannot be considered as independent risk two subgroups of the entity. -
Key Words, General Index (1/1991-1/2016)
Key words, general index (1/1991-1/2016) The number on the left indicates the initial page of the original article, whereas the number on the right of the bar-line indicates the year of publication of European Journal of Pediatric Dermatology. The numbers followed by “t” refer to the page of the Practical Pediatric Dermatology; the numbers followed by “d” refer to the page of the Pediatric Dermoscopy Book. They are followed, after the bar-line, by the year of publication. Absorption, percutaneous, Alopecia, break dance 92/06, 254/15 Anitis, streptococcal 19/09 newborn 157/91 Alopecia areata 63/09 Anonychia, congenital 253/08 Acanthosis nigricans 85/03 dermoscopy 132/09, 133/09 Antimycotic drugs 33/00 Crouzon, syndrome 209/96 Down 7/14 Antihistamines 161/00 Acitretin 151/09 incognita 187/14 APEC 133/94, 21/96 Acne 337t/98 neonatal 56/11, 252/14 Aplasia cutis port-wine 256/11 tacrolimus 227/07 antithyroid drugs 117/05 violinist 120/11 Alopecia, localized of the scalp 201/92 bullous-like 148/10, 174/15 vs angiofibromas 135/99 Alopecia, triangular, familial 50/13 Acne congenital 57/11, 132/09 gangrenous 91/09 cystic rosacea-like 7/13 dermoscopy 133/09 pseudohermaphrod. 169/98 Acne, neonatal normal tuft 273/10 xipho-umbilical 180/114 retinoids 81/98 Alopecia, universalis Appendix, angiofibr. vs atopic dermatitis 10/92 mental retardation 29/92 lip 215/06 Acne, steroid 282/12 Amniotic band 582/02, Ash, dermatitis 734t/04 Acne, vulgaris 185/10 221/06 Atenolol 179/12 Acremoniasis 71/11 Anagen effluvium 606t/02 Atopy Acrocyanosis 842t/06 Anatomical -
Jennifer a Cafardi the Manual of Dermatology 2012
The Manual of Dermatology Jennifer A. Cafardi The Manual of Dermatology Jennifer A. Cafardi, MD, FAAD Assistant Professor of Dermatology University of Alabama at Birmingham Birmingham, Alabama, USA [email protected] ISBN 978-1-4614-0937-3 e-ISBN 978-1-4614-0938-0 DOI 10.1007/978-1-4614-0938-0 Springer New York Dordrecht Heidelberg London Library of Congress Control Number: 2011940426 © Springer Science+Business Media, LLC 2012 All rights reserved. This work may not be translated or copied in whole or in part without the written permission of the publisher (Springer Science+Business Media, LLC, 233 Spring Street, New York, NY 10013, USA), except for brief excerpts in connection with reviews or scholarly analysis. Use in connection with any form of information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed is forbidden. The use in this publication of trade names, trademarks, service marks, and similar terms, even if they are not identifi ed as such, is not to be taken as an expression of opinion as to whether or not they are subject to proprietary rights. While the advice and information in this book are believed to be true and accurate at the date of going to press, neither the authors nor the editors nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein. Printed on acid-free paper Springer is part of Springer Science+Business Media (www.springer.com) Notice Dermatology is an evolving fi eld of medicine. -
Diagnoselijst Dermatologie 2020
Diagnoselijst 2020 ICD-10 DBC AAA-syndroom E27.4 28 aandoening van follikel L73.9 12 aandoening van ooglid H02.9 27 aandoeningen van glandula Bartholini, niet gespecificeerd N75.9 4 aangeboren huidafwijking nno Q82.9 27 aardbeientong K14.8 4 Aarskog syndroom Q87.1 11 abces van glandula Bartholini N75.1 4 abces van neus J34.0 4 abces van uitwendig oor H60.0 4 abces van vinger L02.4 4 abcessus cutis L02.9 4 abcessus subungualis L03.0 4 acantholytische dermatose L11.9 13 acantholytische dermatosen, overige L11.8 13 acantholytische dyskeratotische epidermale naevus D23.9 15 acanthoma basosquamosum D23.9 3 acanthoma fissuratum D23.3 3 acanthoma nno D23.9 3 acanthoma, large cell D23.9 3 acanthosis nigricans nno L83 27 acanthosis nigricans, verworven, benigne L83 27 acanthosis nigricans, verworven, maligne L83 27 acanthosis nigricans, verworven, nno L83 27 acanthosis palmaris (tripe hands) L83 27 accessoire borst (mamma supplementaria) Q83.1 11 accessoire oorschelp (auriculum supplementarium) Q17.0 27 accessoire tepel (mamilla supplementaria) Q83.3 11 achromia congenitaal E70.3 11 acne aestivalis (Mallorca acne) L70.8 1 acne agminata L92.8 27 acne cicatricialis L70.8 1 acne comedonica L70.0 1 acne conglobata L70.1 1 acne cystica L70.0 1 acne door chloor (chlooracne) L70.8 1 acne door geneesmiddelen, inwendig gebruik L70.8 1 acne door olie (olie acne) L70.8 1 acne door steroïden (steroïd acne) L70.8 1 acné excoriée des jeunes filles L70.5 1 acne fulminans L70.8 1 acne indurata L70.0 1 acne infantum L70.4 1 acne keloidalis L73.0 1 acne keloidalis -
Dermatology Syllabus Guidance August 2021
Dermatology Syllabus Guidance August 2021 Preface This document is produced by the British Association of Dermatologists (BAD) Education Subcommittee, in conjunction with the Joint Royal College of Physicians Training Board (JRCPTB) Dermatology Specialist Advisory Committee (SAC). Led by the BAD Academic Vice President and the Chair of the Dermatology SAC, the Syllabus Guidance is to be used as a supporting document for the GMC 2021 Dermatology Curriculum. It provides detailed competencies to support the high-level Capabilities in Practice (CiPs) outlined in the curriculum. The competencies listed in the Syllabus Guidance are not exhaustive, nor should they be used as a “tick box” exercise to automatically presume the learner’s ability to practice independently. Instead, the Syllabus Guidance is an accepted agreed standard which should be used to guide both dermatology trainers and trainees. It catalogues the knowledge, skills and behaviours within the scope of practice of a consultant dermatologist working independently in secondary care. Suggested teaching and learning methods are also indicated. Achievement of various competences encompassing the breadth and depth of the Syllabus Guidance can be used as evidence to support attainment of the six generic and seven dermatology-specific CiPs in the 2021 Dermatology Curriculum. Dermatology Syllabus Guidance August 2021 Page 2 of 54 Contents 2021 Dermatology Curriculum Capabilities in Practice .................................... 5 Developing Professionalism ...............................................................................